This article discusses the use of microneedles in automated diabetes therapy systems. Advanced bioengineered systems have the potential to close the loop between diagnostic and therapeutic elements of diabetes treatment, thus constituting a “smart” system. Prevalent insulin therapies, and most glucose sensing techniques, involve the transfer of physical entities through the skin. Micromachined needles (microneedles) can achieve this in a noninvasive or minimally invasive manner while contributing various other technological merits. The dynamics of autonomous diabetes therapy systems include highly complex interdependencies between the various physical and biological entities involved, thus warranting multidisciplinary research initiatives. The iterative development of a noninvasive, bioengineered interface such as microneedles necessitates a better understanding of the human skin, its molecular architecture as a polymer film, and its role as a functional biological unit. This review addresses application-specific requirements of a microneedle-based interface system specifically for autonomous diabetes therapy. Key design issues and related parametric interdependencies specific to this application are discussed.
DavidsonMB.Starting insulin therapy in type 2 diabetic patients: does it really matter how?Diabetes Care. 2005;28 (2): 494–5.
2.
BlondeL.Easing the transition to insulin therapy in people with type 2 diabetes. Diabetes Educ. 2007;33Suppl 7: 232S–240S.
3.
KhannaPHoathSSmallwoodRBhansaliS.The challenge of human skin-engineering the biotic/abiotic interface. Smart Biosensor Technology, CRC Press, 2007; p 249–68.
RenardE.Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy. Curr Opin Pharmacol. 2002;2 (6): 708–16.
6.
SteilGMPanteleonAERebrinK.Closed-loop insulin delivery-the path to physiological glucose control. Adv Drug Deliv Rev. 2004;56 (2): 125–44.
7.
JeffreyD.Newman JD, Turner AP. Home blood glucose biosensors: a commercial perspective. Biosens Bioelectron. 2005;20 (12): 2435–53.
8.
BodenlenzMSchauppLADrumlTSommerRWutteASchallerHCSinnerFWachPPieberTR.Measurement of interstitial insulin in human adipose and muscle tissue under moderate hyperinsulinemia by means of direct interstitial access. Am J Physiol Endocrinol Metab. 2005;289 (2): E296–300.
9.
RenardE.Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy. Curr Opin Pharmacol. 2002;2 (6): 708–16.
10.
GuerciBBenichouMFloriotMBohmePFougnotSFranckPDrouinP.Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patients. Diabetes Care. 2003;26 (4): 1137–41.
11.
TierneyMJTamadaJAPottsROJovanovicLGargS; Cygnus Research Team. Clinical evaluation of the GlucoWatch biographer: a continual, non-invasive glucose monitor for patients with diabetes. Biosens Bioelectron. 2001;16 (9–12): 621–9.
12.
SchierGMMosesRGGanIEBlairSC.An evaluation and comparison of Reflolux II and Glucometer II, two new portable reflectance meters for capillary blood glucose determination. Diabetes Res Clin Pract. 1988;4 (3): 177–81.
13.
HellerA.Implanted electrochemical glucose sensors for the management of diabetes. Annu Rev Biomed Eng. 1999;1: 153–75.
14.
KostJMitragotriSGabbayRAPishkoMLangerR.Transdermal monitoring of glucose and other analytes using ultrasound. Nat Med. 2000;6 (3): 347–50.
15.
CaduffAHirtEFeldmanYAliZHeinemannL.First human experiments with a novel non-invasive, non-optical continuous glucose monitoring system. Biosens Bioelectron. 2003;19 (3): 209–17.
16.
BurmeisterJJArnoldMA.Evaluation of measurement sites for noninvasive blood glucose sensing with near-infrared transmission spectroscopy. Clin Chem. 1999;45 (9): 1621–7.
17.
ParkerRSDoyleFJ3rdPeppasNA. The intravenous route to blood glucose control. IEEE Eng Med Biol Mag. 2001;20 (1): 65–73.
18.
LenhardMJReevesGD.Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med. 2001;161 (19): 2293–300.
19.
PittHASaudekCDZacurHA.Long-term intraperitoneal insulin delivery. Ann Surg. 1992;216 (4): 483–92.
20.
Gómez-PérezFJRullJA.Insulin therapy: current alternatives. Arch Med Res. 2005;36 (3): 258–72.
21.
TakahashiDXiaoYHuF.A survey of insulin-dependent diabetes—Part II: Control methods. Int J Telemed Appl. 2008: 739–385.
22.
SpencerWJ.A review of programmed insulin delivery systems. IEEE Trans Biomed Eng. 1983;28 (3): 237–51.
23.
CaduffAHirtEFeldmanYAliZHeinemannL.First human experiments with a novel non-invasive, non-optical continuous glucose monitoring system. Biosens Bioelectron. 2003;19 (3): 209–17.
24.
KaushikSHordAHDensonDDMcAllisterDVSmitraSAllenMGPrausnitzMR.Lack of pain associated with microfabricated microneedles. Anesth Analg. 2001;92 (2): 502–4.
25.
GillHSDensonDDBurrisBAPrausnitzMR.Effect of microneedle design on pain in human volunteers. Clin J Pain. 2008;24 (7): 585–94.
26.
BeebeDJMensingGAWalkerGM.Physics and applications of microfluidics in biology. Annu Rev Biomed Eng. 2002;4: 261–86.
27.
Structure of the skin, Microsoft Encarta Encylopedia. http://encarta.msn.com. 1993–2005Microsoft Corporation.
28.
KulcuETamadaJAReachGPottsROLeshoMJ.Physiological differences between interstitial glucose and blood glucose measured in human subjects. Diabetes Care. 2003;26 (8): 2405–9.
29.
StoutPJPeledNEricksonBJHilgersMERacchiniJRHoeghTB.Comparison of glucose levels in dermal interstitial fluid and finger capillary blood. Diabetes Technol Ther. 2001;3 (1): 81–90.
30.
BoyneMSSilverDMKaplanJSaudekCD.Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes. 2003;52 (11): 2790–4.
DavisSPLandisBJAdamsZHAllenMGPrausnitzMR.Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force. J Biomech. 2004;37 (8): 1155–63.
33.
MartantoWBaischSMCostnerEAPrausnitzMRSmithMK.Fluid dynamics in conically tapered microneedles. AIChE J. 2005;51 (6): 1599–607.
34.
MukerjeeEVCollinsSDIsseroffRRSmithRL.Microneedle array for transdermal biological fluid extraction and in situ analysis. Sens Actuat A Phys. 2004;114 (2–3): 267–75.
35.
CollisonMEStoutPJGlushkoTSPokelaKNMullins-HirteDJRacchiniJRWalterMAMeccaSPRundquistJAllenJJHilgersMEHoeghTB.Analytical characterization of electrochemical biosensor test strips for measurement of glucose in low-volume interstitial fluid samples. Clin Chem. 1999;45 (9): 1665–73.
36.
WangPMCornwellMPrausnitzMR.Minimally invasive extraction of dermal interstitial fluid for glucose monitoring using microneedles. Diabetes Technol Ther. 2005;7 (1): 131–41.
37.
MoonSJLeeSS.A novel fabrication method of a microneedle array using inclined deep x-ray exposure. J Micromech Microeng. 2005;15: 903–11.
38.
BrazzleJPapautskyIFrazierAB.Micromachined needle arrays for drug delivery or fluid extraction. IEEE Eng Med Biol Mag. 1999;18 (6): 53–8.
39.
TsuchiyaKNakanishiNUetsujiYNakamachiE.Development of blood extraction system for health monitoring system. Biomed Microdevices. 2005;7 (4): 347–53.
40.
GattikerGEKalerKVMintchevMP.Electronic Mosquito: designing a semi-invasive microsystem for blood sampling, analysis and drug delivery applications. Microsystem Technol. 2005;12 (1–2): 44–51.
41.
ParkJHAllenMGPrausnitzMR.Polymer microneedles for controlled-release drug delivery. Pharm Res. 2006;23 (5): 1008–19.
42.
ParkJHAllenMGPrausnitzMR.Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Control Release. 2005;104 (1): 51–66.
43.
DavisSPMartantoWAllenMGPrausnitzMR.Hollow metal microneedles for insulin delivery to diabetic rats. IEEE Trans Biomed Eng. 2005;52 (5): 909–15.
RodriguezAMolineroDValeraETrifonovTMarsalLFPallaresJAlcubillaR.Fabrication of silicon oxide microneedles from macroporous silicon. Sens Actuat B Chem. 2005;109 (1): 135–40.
46.
RajaramanSHendersonHT.A unique fabrication approach for microneedles using coherent porous silicon technology. Sens Actuat B Chem. 2005;105 (2): 443–8.
47.
PaikSJByunSLimJMParkYLeeAChungSChangJ JunkeunChunK KukjinChoD.In-plane single-crystal-silicon microneedles for minimally invasive microfluid systems. Sens Actuat A Phys. 2004;114 (2–3): 276–84.
48.
GardeniersHJLuttgeRBerenschotEJde BoerMJYeshurunSYHefetzMvan't OeverRvan den BergA. Silicon micromachined hollow microneedles for transdermal liquid transport. J Microelectromech Syst2003;12 (6): 855–62.
49.
WilkeNHibertCO'BrienJMorrisseyA.Silicon microneedle electrode array with temperature monitoring for electroporation. Sens Actuat A Phys. 2005;123–124: 319–25.
50.
MartantoWMooreJSKashlanOKamathRWangPMO'NealJMPrausnitzMR.Microinfusion using hollow microneedles. Pharm Res. 2006;23 (1): 104–13.
51.
MartantoWDavisSPHolidayNRWangJGillHSPrausnitzMR.Transdermal delivery of insulin using microneedles in vivo.Pharm Res. 2004;21 (6): 947–52.
52.
PerennesFMarmiroliBMatteucciMTormenMVaccariLDi FabrizioE. Sharp beveled tip hollow microneedle arrays fabricated by LIGA and 3D soft lithography with polyvinyl alcohol. J Micromech Microeng. 2006;16: 473–9.
53.
GrissPStemmeG.Novel, side opened out-of-plane microneedles for microfluidic transdermal interfacing. Micro Electro Mechanical Systems, 2002. The Fifteenth IEEE International Conference; 2002 Jan 20–24. p 467–70.
54.
ZhangPJullienGA.Microneedle arrays for drug delivery and fluid extraction. MEMS, NANO and Smart Systems, 2005. Proceedings International Conference; 2005 Jul 24–27. p 392–5.
55.
StoeberBLiepmannD.Arrays of hollow out-of-plane microneedles for drug delivery. J Microelectromech Syst. 2005;14 (3): 472–9.
